Skip to content
PubMed This is a summary of 60 peer-reviewed journal articles Updated
Hematology

Adult-Onset Autosomal Recessive Sideroblastic Anemia: A Patient Guide

At a Glance

Adult-onset autosomal recessive sideroblastic anemia is a rare inherited disorder that disrupts red blood cell production and traps iron inside developing blood cells. Genetic testing, bone marrow findings, and ongoing iron monitoring help confirm the diagnosis and protect organs.

Adult-Onset Autosomal Recessive Sideroblastic Anemia is a term for a rare group of congenital (inherited) conditions that change how your body produces its most vital resource: red blood cells. While genetic conditions are often associated with childhood, this specific group of anemias frequently remains unrecognized or undiagnosed until adulthood, sometimes because the genetic variant is “milder” or because the body has found ways to compensate for years [1][2]. Receiving this diagnosis often marks the end of a long search for answers, shifting the focus from unexplained fatigue to a clear, genetically defined path forward.

At its core, this condition is a disorder of the mitochondria, the microscopic powerhouses inside your cells. In your red blood cell precursors, a genetic “roadblock” prevents iron from being incorporated efficiently into hemoglobin, the protein that carries oxygen throughout your body. Instead of being used, this iron becomes trapped and piles up inside the mitochondria. Under a microscope with a special stain, this creates a distinctive pattern of iron granules encircling the nucleus, known as ring sideroblasts [3][4]. This cellular “traffic jam” leads to ineffective red blood cell production, meaning your bone marrow works hard to create cells that are ultimately defective and cannot survive in your bloodstream.

One of the most important things to understand is that this is not a single disease, but a diverse family of genetic variants. Depending on which specific gene is affected—such as SLC25A38, GLRX5, or YARS2—the condition may be “monosyndromic,” affecting only your blood, or “syndromic,” meaning it can also impact your heart, muscles, or immune system [5][6]. Because of this complexity, confirming your exact genetic blueprint is a critical piece of the puzzle, working alongside your clinical history and bone marrow results to help distinguish this inherited condition from acquired adult disorders like Myelodysplastic Syndrome (MDS) [7][8].

Living with this condition requires a proactive approach to long-term health, particularly regarding iron overload. Because your bone marrow’s ineffective attempts to make blood send signals (like inappropriately low hepcidin) that tell your body to absorb more iron, iron can gradually build up in your liver and heart, potentially causing damage over time [9][10]. This risk exists even for patients who do not require frequent blood transfusions, though you should never start or stop iron supplements without your doctor confirming your specific levels. By working with a specialized multi-disciplinary team, you can monitor these levels and use personalized therapies to protect your organs, manage your energy, and navigate the unique challenges of this rare diagnosis with confidence.

Common questions in this guide

What is adult-onset autosomal recessive sideroblastic anemia?
It is a rare inherited group of blood disorders that can first be recognized in adulthood. Genetic changes disrupt how developing red blood cells use iron to make hemoglobin, leading to ineffective red blood cell production and iron accumulation.
How do doctors tell whether this anemia is inherited or acquired?
Doctors combine your medical history with blood and bone marrow findings and genetic testing. This overall assessment can support an inherited diagnosis and help distinguish it from acquired conditions such as myelodysplastic syndrome, also called MDS.
What are ring sideroblasts, and why do they matter?
Ring sideroblasts are developing red blood cells whose mitochondria contain iron granules arranged around the nucleus. They are a characteristic finding in sideroblastic anemia, but genetic testing and the rest of the evaluation are needed to identify the inherited form.
Can iron overload occur even if I do not get regular blood transfusions?
Yes. Ineffective red blood cell production can send signals that increase iron absorption, allowing iron to build up even without frequent transfusions. Regular iron assessment is important, and you should not start or stop iron supplements without medical guidance.
Could my specific gene change affect organs besides my blood?
Some gene-related forms mainly affect blood production, while syndromic forms may also involve the heart, muscles, or immune system. The identified gene and your symptoms help your care team decide whether additional monitoring is needed.
Which specialists should be involved in my care?
A hematologist can coordinate care with a medical genetics professional and other specialists when needed. The team can tailor follow-up for blood counts, iron levels, and organs such as the heart and muscles.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my specific genetic mutation primarily affect my blood production, or should we be monitoring other organ systems like my heart or muscles?
  2. 2.How can we use my clinical history, bone marrow, and genetic testing together to be certain this is an inherited condition rather than an acquired disorder like MDS?
  3. 3.What is our plan for monitoring my iron levels, and at what point would we need to start treatment to protect my organs?
  4. 4.Given the rarity of this condition, how can we ensure my care is coordinated between my hematologist and any other necessary specialists?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    The phenotypic spectrum of germline YARS2 variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2.

    Riley LG, Heeney MM, Rudinger-Thirion J, et al.

    Haematologica 2018; (103(12)):2008-2015 doi:10.3324/haematol.2017.182659.

    PMID: 30026338
  2. 2

    Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing.

    Cazzola M, Malcovati L

    Hematology. American Society of Hematology. Education Program 2015; (2015()):19-25 doi:10.1182/asheducation-2015.1.19.

    PMID: 26637696
  3. 3

    Characterization of Human and Yeast Mitochondrial Glycine Carriers with Implications for Heme Biosynthesis and Anemia.

    Lunetti P, Damiano F, De Benedetto G, et al.

    The Journal of biological chemistry 2016; (291(38)):19746-59 doi:10.1074/jbc.M116.736876.

    PMID: 27476175
  4. 4

    Causes and Pathophysiology of Acquired Sideroblastic Anemia.

    Rodriguez-Sevilla JJ, Calvo X, Arenillas L

    Genes 2022; (13(9)) doi:10.3390/genes13091562.

    PMID: 36140729
  5. 5

    Clinical characterization and hematopoietic stem cell transplant outcomes for congenital sideroblastic anemia caused by a novel pathogenic variant in SLC25A38.

    Uminski K, Houston DS, Hartley JN, et al.

    Pediatric blood & cancer 2020; (67(10)):e28623 doi:10.1002/pbc.28623.

    PMID: 32790119
  6. 6

    Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy.

    Sommerville EW, Ng YS, Alston CL, et al.

    JAMA neurology 2017; (74(6)):686-694 doi:10.1001/jamaneurol.2016.4357.

    PMID: 28395030
  7. 7

    Sideroblastic anemia in children: challenges in diagnosis and management in three cases.

    Rekaya S, Ben Fraj I, Hamdi R, et al.

    Annals of hematology 2025; (104(4)):2537-2543 doi:10.1007/s00277-025-06266-5.

    PMID: 40042629
  8. 8

    Understanding Sideroblastic Anemia: An Overview of Genetics, Epidemiology, Pathophysiology and Current Therapeutic Options.

    Abu-Zeinah G, DeSancho MT

    Journal of blood medicine 2020; (11()):305-318 doi:10.2147/JBM.S232644.

    PMID: 33061728
  9. 9

    Differentiating iron-loading anemias using a newly developed and analytically validated ELISA for human serum erythroferrone.

    Diepeveen L, Roelofs R, Grebenchtchikov N, et al.

    PloS one 2021; (16(7)):e0254851 doi:10.1371/journal.pone.0254851.

    PMID: 34283879
  10. 10

    Pathophysiology and classification of iron overload diseases; update 2018.

    Brissot P, Troadec MB, Loréal O, Brissot E

    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 2019; (26(1)):80-88 doi:10.1016/j.tracli.2018.08.006.

    PMID: 30173950

This page is for informational purposes only and does not constitute medical advice. A hematologist and genetics team should interpret your genetic, bone marrow, and iron results and guide your care.

Get notified when new evidence is published on Adult-onset autosomal recessive sideroblastic anemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.